BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 7513038)

  • 1. Himbacine discriminates between putative muscarinic M1 receptor-mediated responses.
    Sagrada A; Duranti P; Giudici L; Schiavone A
    Life Sci; 1994; 54(17):PL305-10. PubMed ID: 7513038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of field stimulation-induced contractions of rabbit vas deferens by muscarinic receptor agonists: selectivity of McN-A-343 for M1 receptors.
    Davies RH; Scholes HE; Virdi S; Broadley KJ
    J Pharm Pharmacol; 2001 Apr; 53(4):487-96. PubMed ID: 11341365
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Muscarinic M1 receptor agonist actions of muscarinic receptor agonists in rabbit vas deferens.
    Shannon HE; Sawyer BD; Bemis KG; Bymaster FP; Health I; Mitch CH; Ward JS
    Eur J Pharmacol; 1993 Feb; 232(1):47-57. PubMed ID: 8458395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Binding and functional selectivity of himbacine for cloned and neuronal muscarinic receptors.
    Miller JH; Aagaard PJ; Gibson VA; McKinney M
    J Pharmacol Exp Ther; 1992 Nov; 263(2):663-7. PubMed ID: 1331410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of selectivity of muscarinic antagonists for M1 and M2 receptors in rabbit isolated vas deferens.
    Eltze M
    Pharmacology; 1988; 37 Suppl 1():40-7. PubMed ID: 2467317
    [TBL] [Abstract][Full Text] [Related]  

  • 6. 4-DAMP analogues reveal heterogeneity of M1 muscarinic receptors.
    Micheletti R; Giudici L; Turconi M; Donetti A
    Br J Pharmacol; 1990 Jul; 100(3):395-7. PubMed ID: 1697193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Presynaptic muscarinic receptors mediating inhibition of neurogenic contractions in rabbit vas deferens are of the ganglionic M1-type.
    Eltz M; Gmelin G; Wess J; Strohmann C; Tacke R; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1988 Dec; 158(3):233-42. PubMed ID: 2472963
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of muscarinic receptors mediating relaxation and contraction in the rat iris dilator muscle.
    Masuda Y; Yamahara NS; Tanaka M; Ryang S; Kawai T; Imaizumi Y; Watanabe M
    Br J Pharmacol; 1995 Feb; 114(4):769-76. PubMed ID: 7539696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of extracellular calcium concentration on potency of muscarinic agonists at M1 and M2 receptors in rabbit vas deferens.
    Dörje F; Rettenmayr NM; Mutschler E; Lambrecht G
    Eur J Pharmacol; 1991 Oct; 203(3):417-20. PubMed ID: 1723047
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of the prejunctional muscarinic receptors mediating inhibition of evoked release of endogenous noradrenaline in rabbit isolated vas deferens.
    Grimm U; Fuder H; Moser U; Bümert HG; Mutschler E; Lambrecht G
    Naunyn Schmiedebergs Arch Pharmacol; 1994 Jan; 349(1):1-10. PubMed ID: 8139696
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional determination of McN-A-343 affinity for M1 muscarinic receptors.
    Micheletti R; Schiavone A
    J Pharmacol Exp Ther; 1990 Apr; 253(1):310-4. PubMed ID: 1691785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M(2)/M(4)-muscarinic receptors mediate automodulation of acetylcholine outflow from mouse cortex.
    Iannazzo L; Majewski H
    Neurosci Lett; 2000 Jun; 287(2):129-32. PubMed ID: 10854729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the muscarinic receptor subtype mediating inhibition of the neurogenic contractions in rabbit isolated vas deferens by a series of polymethylene tetra-amines.
    Budriesi R; Cacciaguerra S; Toro RD; Bolognesi ML; Chiarini A; Minarini A; Rosini M; Spampinato S; Tumiatti V; Melchiorre C
    Br J Pharmacol; 2001 Mar; 132(5):1009-16. PubMed ID: 11226131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The affinity, selectivity and biological activity of telenzepine enantiomers.
    Schudt C; Boer R; Eltze M; Riedel R; Grundler G; Birdsall NJ
    Eur J Pharmacol; 1989 Jun; 165(1):87-96. PubMed ID: 2475354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (+/-)-Terodiline: an M1-selective muscarinic receptor antagonist. In vivo effects at muscarinic receptors mediating urinary bladder contraction, mydriasis and salivary secretion.
    Noronha-Blob L; Prosser JC; Sturm BL; Lowe VC; Enna SJ
    Eur J Pharmacol; 1991 Aug; 201(2-3):135-42. PubMed ID: 1724648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presynaptic M2-muscarinic receptors on noradrenergic nerve endings and endothelium-derived M3 receptors in cat cerebral arteries.
    Alonso MJ; Arribas S; Marín J; Balfagón G; Salaices M
    Brain Res; 1991 Dec; 567(1):76-82. PubMed ID: 1726141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathways involved in muscarinic M1 and M2 receptor stimulation in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1994 Sep; 263(1-2):31-7. PubMed ID: 7529712
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscarinic M1- and M2-receptors mediating opposite effects on neuromuscular transmission in rabbit vas deferens.
    Eltze M
    Eur J Pharmacol; 1988 Jul; 151(2):205-21. PubMed ID: 2844551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of antimuscarinic toxins to facilitate studies of striatal m4 muscarinic receptors.
    Purkerson SL; Potter LT
    J Pharmacol Exp Ther; 1998 Feb; 284(2):707-13. PubMed ID: 9454818
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selectivity profile of the novel muscarinic antagonist UH-AH 37 determined by the use of cloned receptors and isolated tissue preparations.
    Wess J; Lambrecht G; Mutschler E; Brann MR; Dörje F
    Br J Pharmacol; 1991 Jan; 102(1):246-50. PubMed ID: 2043926
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.